Constellation Pharmaceuticals Announces $65 Million Private Placement with New and Existing Investors

Editas Medicine to Participate in Upcoming Investor Conferences

Fulcrum Therapeutics Announces Multiple Presentations of Losmapimod Data at World Muscle Society Meeting

GBT to Host Analyst & Investor Day on October 8 in New York

Jounce Therapeutics to Present Two Posters from the JTX-4014 and Vopratelimab Programs at the Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting